Paras Healthcare IPO Subscription: What Investors Are Buying in the Hospital Group
The Paras Healthcare IPO subscription closed at 2.34 times. A look at the hospital business, the profit turnaround and the offer structure.
Get the latest industry insights and trends in the pharmaceutical sector with Med Pharma News. Stay informed about groundbreaking research, regulatory updates, and market analysis.
The Paras Healthcare IPO subscription closed at 2.34 times. A look at the hospital business, the profit turnaround and the offer structure.
What Talkiatry therapy services nationwide mean for patients on psychiatric medication: coverage, claims, and the questions still unanswered.
The US Ebola travel declaration is the latest step after May and July entry bars. A timeline of the rules, what changes on 3 November and what is unknown.
The Shamonda virus human case in France: official statements, the ECDC comment, the animal context and the open questions investigators are working on.
The Cencora American Oncology Network acquisition is valued at up to $2.4 billion. What was disclosed, what was not, and what to watch.
Vaccine research ethics under scrutiny after a halted Guinea-Bissau newborn trial: consent, control arms, approvals and what regulators ask.
Healthcare company spin-offs are in focus as Abbott plans to separate nutrition by end-2027. How spin-offs work, and what to read in the filing.
Cell and gene therapy manufacturing India: what the Nucelion and VeGen Bio CRDMO deal covers, and what it leaves out, from marketing to the 2028 target.
MMR vaccination is rising as Pennsylvania measles reaches 1,317 cases: over 56,000 provider doses in September and 10,000 by state nurses.